SAM
SAGE
Shell Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,405
| Closed | -$282K | – | 1316 |
|
|
2022
Q4 | $282K | Sell |
7,405
-1,556
| -17% | -$59.3K | 0.01% | 810 |
|
|
2022
Q3 | $351K | Sell |
8,961
-2,348
| -21% | -$92K | 0.01% | 752 |
|
|
2022
Q2 | $365K | Buy |
11,309
+18
| +0.2% | +$581 | 0.01% | 884 |
|
|
2022
Q1 | $374K | Sell |
11,291
-1,672
| -13% | -$55.4K | 0.01% | 950 |
|
|
2021
Q4 | $551K | Buy |
12,963
+2,712
| +26% | +$115K | 0.01% | 858 |
|
|
2021
Q3 | $454K | Sell |
10,251
-440
| -4% | -$19.5K | 0.01% | 915 |
|
|
2021
Q2 | $607K | Buy |
10,691
+580
| +6% | +$32.9K | 0.01% | 825 |
|
|
2021
Q1 | $757K | Buy |
10,111
+5,723
| +130% | +$428K | 0.02% | 654 |
|
|
2020
Q4 | $380K | Hold |
4,388
| – | – | 0.01% | 908 |
|
|
2020
Q3 | $268K | Hold |
4,388
| – | – | 0.01% | 950 |
|
|
2020
Q2 | $182K | Sell |
4,388
-85
| -2% | -$3.53K | ﹤0.01% | 1044 |
|
|
2020
Q1 | $128K | Sell |
4,473
-70
| -2% | -$2K | ﹤0.01% | 1087 |
|
|
2019
Q4 | $328K | Sell |
4,543
-132
| -3% | -$9.53K | 0.01% | 1034 |
|
|
2019
Q3 | $656K | Sell |
4,675
-40
| -0.8% | -$5.61K | 0.02% | 749 |
|
|
2019
Q2 | $863K | Sell |
4,715
-109
| -2% | -$20K | 0.02% | 628 |
|
|
2019
Q1 | $767K | Buy |
4,824
+2,404
| +99% | +$382K | 0.02% | 705 |
|
|
2018
Q4 | $232K | Sell |
2,420
-200
| -8% | -$19.2K | 0.01% | 1020 |
|
|
2018
Q3 | $370K | Hold |
2,620
| – | – | 0.01% | 1034 |
|
|
2018
Q2 | $410K | Sell |
2,620
-100
| -4% | -$15.6K | 0.01% | 977 |
|
|
2018
Q1 | $438K | Buy |
+2,720
| New | +$438K | 0.01% | 946 |
|